Insulet’s wearable insulin patch Omnipod may be able to seamlessly control insulin delivery for patients with diabetes, but ...
In what GSK says represents a potential way to transform treatment for patients with certain types of rectal cancer, the ...
In an initiative to increase the efficiency of drug manufacturing in the United States, the FDA has proposed a streamlined ...
Even as the effort has met with fierce pushback from drugmakers, trade groups and opposition parties in the country’s own ...
Lupin Pharmaceuticals, the U.S. unit of India’s Lupin Limited, issued a voluntary recall of more than 2.5 million bottles of prednisolone acetate ophthalmic suspension after an undisclosed contaminant ...
The transaction's two focuses, Palsonify and atumelnant, have combined peak sales potential of more than $5 billion, Vertex ...
In biopharmaceutical R&D, where fewer than 1 in 10 development programs ultimately reach approval, risk assessment remains central to portfolio strategy and investment decisions. For more than two ...
Sanofi has scored FDA approval for its subcutaneous version of Sarclisa, giving the multiple myeloma treatment a potential ...
AI has moved from emerging capability to executive mandate, yet many organizations are still struggling to translate ...
The pharmaceutical industry is reaching a turning point in patient support. | Life sciences leaders say patient support is ...
Aiming to streamline the compensation process for people claiming harm from COVID-19 vaccines, Robert F. | Aiming to ...
The increasingly more popular combination of Padcev and Keytruda has expanded its bladder cancer territory once again. Thanks to an FDA nod on July 10, Padcev and Keytruda have become the first muscle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results